TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that it has launched Cyclobenzaprine Hydrochloride Tablets 5 mg & 10 mg, and Clonidine Hydrochloride Tablets 0.1 mg, 0.2 mg & 0.3 mg on the TruPharma label. The FDA-approved products are being supplied to TruPharma pursuant to a master agreement with Frontida BioPharm, Inc., which includes additional products that TruPharma expects to launch in the next eighteen months.